SOLENO THERAPEUTICS INC·4

Mar 4, 5:59 PM ET

Fulk Jennifer 4

4 · SOLENO THERAPEUTICS INC · Filed Mar 4, 2026

Insider Transaction Report

Form 4
Period: 2026-03-02
Fulk Jennifer
CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-02+39,20039,200 total
  • Exercise/Conversion

    Employee stock option (right to buy)

    [F2]
    2026-03-02+67,66067,660 total
    Exercise: $39.06Exp: 2036-03-02Common Stock (67,660 underlying)
Footnotes (2)
  • [F1]These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. 25% of RSUs shall vest on each of March 2, 2027, March 2, 2028, March 2, 2029 and March 2, 2030, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.
  • [F2]One-fourth of the shares subject to the option shall vest on March 2, 2027 and one forty-eighth of the shares subject to the option shall vest each month thereafter on the same day of the month, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact|2026-03-04

Documents

1 file
  • 4
    form4-03042026_100352.xmlPrimary